(Q42283978)

19 October 2017

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine (English)

1 reference

19 October 2017

0 references

Maes M

1

1 reference

19 October 2017

Meltzer HY

series ordinal

2

1 reference

19 October 2017

Bosmans E

series ordinal

3

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

Acta Psychiatrica Scandinavica

19 October 2017

1 reference

19 October 2017

89

1 reference

19 October 2017

346-351

1 reference

19 October 2017

5

1 reference

Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes?

19 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

Biological significance of soluble IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

A comprehensive macrophage-T-lymphocyte theory of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

The soluble interleukin-6 receptor is generated by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptic-treated chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1994.TB01527.X

10.1111/J.1600-0447.1994.TB01527.X

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference